Merck & Co., Inc. (MRK)
143.93
-0.78
(-0.54%)
USD |
NYSE |
Sep 11, 16:00
144.00
+0.07
(+0.05%)
After-Hours: 20:00
Merck Price to Book Value : 8.473 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 8.473 |
| September 10, 2026 | 8.519 |
| September 09, 2026 | 8.685 |
| September 08, 2026 | 8.74 |
| September 04, 2026 | 8.850 |
| September 03, 2026 | 8.968 |
| September 02, 2026 | 8.927 |
| September 01, 2026 | 8.822 |
| August 31, 2026 | 8.699 |
| August 28, 2026 | 8.734 |
| August 27, 2026 | 8.804 |
| August 26, 2026 | 9.013 |
| August 25, 2026 | 9.210 |
| August 24, 2026 | 8.870 |
| August 21, 2026 | 8.981 |
| August 20, 2026 | 8.771 |
| August 19, 2026 | 8.960 |
| August 18, 2026 | 7.958 |
| August 17, 2026 | 8.005 |
| August 14, 2026 | 7.997 |
| August 13, 2026 | 7.98 |
| August 12, 2026 | 7.825 |
| August 11, 2026 | 7.678 |
| August 10, 2026 | 7.707 |
| August 07, 2026 | 7.570 |
| Date | Value |
|---|---|
| August 06, 2026 | 7.557 |
| August 05, 2026 | 7.555 |
| August 04, 2026 | 7.536 |
| August 03, 2026 | 7.522 |
| July 31, 2026 | 7.665 |
| July 30, 2026 | 7.641 |
| July 29, 2026 | 7.674 |
| July 28, 2026 | 7.760 |
| July 27, 2026 | 7.698 |
| July 24, 2026 | 7.716 |
| July 23, 2026 | 7.682 |
| July 22, 2026 | 7.504 |
| July 21, 2026 | 7.433 |
| July 20, 2026 | 7.324 |
| July 17, 2026 | 7.506 |
| July 16, 2026 | 7.514 |
| July 15, 2026 | 7.277 |
| July 14, 2026 | 7.110 |
| July 13, 2026 | 7.302 |
| July 10, 2026 | 7.273 |
| July 09, 2026 | 7.363 |
| July 08, 2026 | 7.417 |
| July 07, 2026 | 7.586 |
| July 06, 2026 | 7.464 |
| July 02, 2026 | 7.627 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.527 |
| Eli Lilly & Co. | 31.01 |
| Pfizer Inc. | 1.854 |
| Bristol Myers Squibb Co. | 5.825 |
| Viatris, Inc. | 1.338 |
Price to Book Value Related Metrics
| PE Ratio | 115.04 |
| PS Ratio | 5.389 |
| Price to Free Cash Flow | 22.24 |
| Price | 143.93 |
| Earnings Yield | 0.87% |
| Market Cap | 355.31B |
| Operating PE Ratio | 28.66 |
| Normalized PE Ratio | 47.58 |